219 related articles for article (PubMed ID: 27834206)
21. Role of autophagy in the host defense against Toxoplasma gondii in astrocytes.
Halonen SK
Autophagy; 2009 Feb; 5(2):268-9. PubMed ID: 19139630
[TBL] [Abstract][Full Text] [Related]
22. Soluble factors released by Toxoplasma gondii-infected astrocytes down-modulate nitric oxide production by gamma interferon-activated microglia and prevent neuronal degeneration.
Rozenfeld C; Martinez R; Figueiredo RT; Bozza MT; Lima FR; Pires AL; Silva PM; Bonomo A; Lannes-Vieira J; De Souza W; Moura-Neto V
Infect Immun; 2003 Apr; 71(4):2047-57. PubMed ID: 12654825
[TBL] [Abstract][Full Text] [Related]
23. Toxoplasma gondii Inhibits gamma interferon (IFN-γ)- and IFN-β-induced host cell STAT1 transcriptional activity by increasing the association of STAT1 with DNA.
Rosowski EE; Nguyen QP; Camejo A; Spooner E; Saeij JP
Infect Immun; 2014 Feb; 82(2):706-19. PubMed ID: 24478085
[TBL] [Abstract][Full Text] [Related]
24. Functional Analysis of the Role of Toxoplasma gondii Nucleoside Triphosphate Hydrolases I and II in Acute Mouse Virulence and Immune Suppression.
Olias P; Sibley LD
Infect Immun; 2016 Jul; 84(7):1994-2001. PubMed ID: 27091930
[TBL] [Abstract][Full Text] [Related]
25. Neurons are the Primary Target Cell for the Brain-Tropic Intracellular Parasite Toxoplasma gondii.
Cabral CM; Tuladhar S; Dietrich HK; Nguyen E; MacDonald WR; Trivedi T; Devineni A; Koshy AA
PLoS Pathog; 2016 Feb; 12(2):e1005447. PubMed ID: 26895155
[TBL] [Abstract][Full Text] [Related]
26. Astrocytic TGF-β signaling limits inflammation and reduces neuronal damage during central nervous system Toxoplasma infection.
Cekanaviciute E; Dietrich HK; Axtell RC; Williams AM; Egusquiza R; Wai KM; Koshy AA; Buckwalter MS
J Immunol; 2014 Jul; 193(1):139-49. PubMed ID: 24860191
[TBL] [Abstract][Full Text] [Related]
27. Cell-mediated immunity to Toxoplasma gondii: initiation, regulation and effector function.
Yap GS; Sher A
Immunobiology; 1999 Dec; 201(2):240-7. PubMed ID: 10631573
[TBL] [Abstract][Full Text] [Related]
28. A role for inducible costimulator protein in the CD28- independent mechanism of resistance to Toxoplasma gondii.
Villegas EN; Lieberman LA; Mason N; Blass SL; Zediak VP; Peach R; Horan T; Yoshinaga S; Hunter CA
J Immunol; 2002 Jul; 169(2):937-43. PubMed ID: 12097399
[TBL] [Abstract][Full Text] [Related]
29. Flt3 Ligand Is Essential for Survival and Protective Immune Responses during Toxoplasmosis.
Dupont CD; Harms Pritchard G; Hidano S; Christian DA; Wagage S; Muallem G; Tait Wojno ED; Hunter CA
J Immunol; 2015 Nov; 195(9):4369-77. PubMed ID: 26385522
[TBL] [Abstract][Full Text] [Related]
30. IL-12 signaling drives CD8+ T cell IFN-gamma production and differentiation of KLRG1+ effector subpopulations during Toxoplasma gondii Infection.
Wilson DC; Matthews S; Yap GS
J Immunol; 2008 May; 180(9):5935-45. PubMed ID: 18424713
[TBL] [Abstract][Full Text] [Related]
31. CD40 restrains in vivo growth of Toxoplasma gondii independently of gamma interferon.
Subauste CS; Wessendarp M
Infect Immun; 2006 Mar; 74(3):1573-9. PubMed ID: 16495528
[TBL] [Abstract][Full Text] [Related]
32. Reduced expression of the inducible nitric oxide synthase after infection with Toxoplasma gondii facilitates parasite replication in activated murine macrophages.
Lüder CG; Algner M; Lang C; Bleicher N; Gross U
Int J Parasitol; 2003 Jul; 33(8):833-44. PubMed ID: 12865083
[TBL] [Abstract][Full Text] [Related]
33. DNA immunization with eukaryotic initiation factor-2α of Toxoplasma gondii induces protective immunity against acute and chronic toxoplasmosis in mice.
Chen J; Huang SY; Zhou DH; Li ZY; Petersen E; Song HQ; Zhu XQ
Vaccine; 2013 Dec; 31(52):6225-31. PubMed ID: 24183979
[TBL] [Abstract][Full Text] [Related]
34. The mechanism of interferon-gamma induced anti Toxoplasma gondii by indoleamine 2,3-dioxygenase and/or inducible nitric oxide synthase vary among tissues.
Fujigaki S; Takemura M; Hamakawa H; Seishima M; Saito K
Adv Exp Med Biol; 2003; 527():97-103. PubMed ID: 15206721
[TBL] [Abstract][Full Text] [Related]
35. Behavior of Neutrophil Granulocytes during
Biswas A; French T; Düsedau HP; Mueller N; Riek-Burchardt M; Dudeck A; Bank U; Schüler T; Dunay IR
Front Cell Infect Microbiol; 2017; 7():259. PubMed ID: 28680853
[TBL] [Abstract][Full Text] [Related]
36. Phenotype and functions of brain dendritic cells emerging during chronic infection of mice with Toxoplasma gondii.
Fischer HG; Bonifas U; Reichmann G
J Immunol; 2000 May; 164(9):4826-34. PubMed ID: 10779791
[TBL] [Abstract][Full Text] [Related]
37. From cells to signaling cascades: manipulation of innate immunity by Toxoplasma gondii.
Denkers EY
FEMS Immunol Med Microbiol; 2003 Dec; 39(3):193-203. PubMed ID: 14642303
[TBL] [Abstract][Full Text] [Related]
38. Toxoplasma Effector Recruits the Mi-2/NuRD Complex to Repress STAT1 Transcription and Block IFN-γ-Dependent Gene Expression.
Olias P; Etheridge RD; Zhang Y; Holtzman MJ; Sibley LD
Cell Host Microbe; 2016 Jul; 20(1):72-82. PubMed ID: 27414498
[TBL] [Abstract][Full Text] [Related]
39. Toxoplasma gondii inhibits MHC class II expression in neural antigen-presenting cells by down-regulating the class II transactivator CIITA.
Lüder CG; Lang C; Giraldo-Velasquez M; Algner M; Gerdes J; Gross U
J Neuroimmunol; 2003 Jan; 134(1-2):12-24. PubMed ID: 12507768
[TBL] [Abstract][Full Text] [Related]
40. Strain- and Dose-Dependent Reduction of
Jennes M; De Craeye S; Devriendt B; Dierick K; Dorny P; Cox E
Front Cell Infect Microbiol; 2017; 7():232. PubMed ID: 28642841
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
